Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 10 Brain Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Leukemia 9 Glioblastoma 9 Leukemia, Myeloid, Acute 8 Meningioma 7 Head and Neck Neoplasms 7 Gliosarcoma 6 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Laryngeal Neoplasms 3 Esophageal Neoplasms 3 Treatment-Refractory Solid Tumors 2 Thrombocythemia, Essential 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Pharyngeal Neoplasms 2 Paranasal Sinus Neoplasms 2 Oropharyngeal Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2

Interventions

imetelstat 1 Vorinostat 1 Spectroscopy, Near-Infrared 1 Phlebotomy 1 N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1 Hydroxyurea 1 Histone Deacetylase Inhibitors 1 GRN163L peptide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycythemia × Hydroxyurea × Clear all

NCT01645124 2012-07-20

CYTO-PV

Consorzio Mario Negri Sud

Phase 3 Terminated

Polycythemia, Polycythemia Vera, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡